• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.

作者信息

Macdougall I C, Roberts D E, Neubert P, Dharmasena A D, Coles G A, Williams J D

机构信息

KRUF Institute of Renal Disease, University of Wales College of Medicine, Royal Infirmary, Cardiff, UK.

出版信息

Contrib Nephrol. 1989;76:112-20; discussion 120-1. doi: 10.1159/000417887.

DOI:10.1159/000417887
PMID:2684515
Abstract
摘要

相似文献

1
Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.持续性非卧床腹膜透析（CAPD）患者静脉内、腹腔内及皮下注射重组促红细胞生成素的药代动力学。治疗依据。
Contrib Nephrol. 1989;76:112-20; discussion 120-1. doi: 10.1159/000417887.
2
Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lancet. 1989 Feb 25;1(8635):425-7. doi: 10.1016/s0140-6736(89)90014-7.
3
Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.持续性非卧床腹膜透析（CAPD）患者经静脉、皮下和腹腔途径给予重组促红细胞生成素的比较药代动力学。
Perit Dial Int. 1989;9(2):95-8.
4
Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.接受常规血液透析治疗或持续性非卧床腹膜透析的患者静脉内和皮下注射重组促红细胞生成素后的药代动力学和剂量反应。
Nephron. 1991;59(3):399-402. doi: 10.1159/000186598.
5
Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
Eur J Pediatr. 1994 Nov;153(11):850-4. doi: 10.1007/BF01972896.
6
Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析患者腹腔内、静脉内及皮下注射重组人促红细胞生成素的药代动力学
Am J Kidney Dis. 1993 Jun;21(6):635-42. doi: 10.1016/s0272-6386(12)80037-0.
7
Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD.
Contrib Nephrol. 1989;76:122-30. doi: 10.1159/000417888.
8
The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.腹腔内注射未稀释或在透析液中稀释的促红细胞生成素的药代动力学。
Perit Dial Int. 1992;12(4):369-72.
9
Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析患者皮下及腹腔注射重组人促红细胞生成素的药代动力学和药效学
Clin Nephrol. 1990 Jan;33(1):47-51.
10
Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
Perit Dial Int. 1992;12(4):350-2.

引用本文的文献

1
Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?促红细胞生成素治疗慢性肾脏病所致贫血——皮下注射还是静脉注射，目前我们了解多少？
Cureus. 2020 Sep 10;12(9):e10358. doi: 10.7759/cureus.10358.
2
Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).促红细胞生成素（重组人促红细胞生成素）的临床药代动力学
Clin Pharmacokinet. 1991 Feb;20(2):99-113. doi: 10.2165/00003088-199120020-00002.
3
The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.
重组人促红细胞生成素在血液透析患者中的药代动力学和药效学
Br J Clin Pharmacol. 1992 Dec;34(6):499-508.